期刊
DRUG DISCOVERY TODAY
卷 13, 期 11-12, 页码 530-535出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2008.03.018
关键词
-
资金
- NICHD NIH HHS [K23 HD047166-04, K23 HD047166] Funding Source: Medline
By the end of 2006, compared with 28% coverage for adults, only 15% of children with HIV that needed antiretroviral treatment were receiving it. Major challenges in delivering treatment include the lack of paediatric antiretrovirals that can be dosed in small children and limited studies examining safety and efficacy for existing antiretroviral formulations. The high costs of treatment have been reduced through the use of generic, fixed-dose combination drugs. Evidence-based strategies for managing resistance and the scale-up of pharmacological trials for children in low- and middle-income countries are crucial to the success and future development of paediatric antiretrovirals.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据